Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Systemic disease associations with angioid streaks in a large healthcare claims database

Abstract

Background/Objectives

To assess systemic associations of angioid streaks (AS) using a large US healthcare database.

Subjects/Methods

A retrospective cross-sectional study was conducted of patients diagnosed with AS in a large, national US insurer from 2000–2019. Cases were matched 1:5 to controls. The prevalence rates of established associated disease states and other systemic diseases were calculated and compared using logistic regression. Additionally, the rate of anti-VEGF treatment was assessed as a proxy for the incidence of choroidal neovascularization (CNV).

Results

One thousand eight hundred fifty-two cases of AS and 9028 matched controls were included. The rates of association between AS and the well-characterized conditions included: Pseudoxanthoma elasticum (PXE)—228 patients (12.3%), Ehlers–Danlos syndrome—18 patients (1.0%), Paget’s disease—6 patients (0.3%), hemoglobinopathies—30 patients (1.6%), and idiopathic—1573 patients (84.9%). There was a statistically higher prevalence of the following less classically associated diseases among patients with AS compared to controls: hereditary spherocytosis (1.7% vs. 0.6%, p < 0.001), connective tissue disease (1.0% vs 0.3%, p < 0.001) and non-exudative age-related macular degeneration (33.9% vs 10.6%, p < 0.001). Among 1442 eligible cases analyzed, 427 (29.6%) received at least 1 anti-VEGF injection with 338 (23.4%) patients having the injection after their AS diagnosis.

Conclusions

In the largest collection of AS patients to date, the classical teaching of systemic disease associations occur at rates far, far lower than previously reported. The association of AS with other less reported diseases highlights new potential associations and may contribute to the understanding of AS formation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

Data availability

Data for this study were licensed from OptumInsight (Eden Park, MN, USA) by the University of Pennsylvania and due to contractual obligations are not permitted to be made freely available. It is available for licensing directly from the company.

References

  1. Gliem M, Finger RP, Fimmers R, Brinkmann CK, Holz FG, Charbel Issa P. Treatment of choroidal neovascularization due to angioid streaks. Retina. 2013;33:1300–14.

    Article  CAS  PubMed  Google Scholar 

  2. Risseeuw S, Ossewaarde-van Norel J, van Buchem C, Spiering W, Imhof SM, van Leeuwen R. The extent of angioid streaks correlates with macular degeneration in pseudoxanthoma elasticum. Am J Ophthalmol. 2020;220:82–90.

    Article  CAS  PubMed  Google Scholar 

  3. Hagedoorn A. Angioid streaks and traumatic ruptures of Bruch’s membrane. Br J Ophthalmol. 1975;59:267.

  4. Dreyer R, Green WR. The pathology of angioid streaks: a study of twenty-one cases. Trans Pa Acad Ophthalmol Otolaryngol. 1978;31:158–167.

    CAS  PubMed  Google Scholar 

  5. Chatziralli I, Saitakis G, Dimitriou E, Chatzirallis A, Stoungioti S, Theodossiadis G, et al. ANGIOID STREAKS: a comprehensive review from pathophysiology to treatment. Retina. 2019;39:1–11.

    Article  CAS  PubMed  Google Scholar 

  6. Kerr NM. Ocular manifestations of juvenile Paget disease. Arch Ophthalmol. 2010;128:698.

    Article  PubMed  Google Scholar 

  7. Clarkson JG, Altman RD. Angioid streaks. Surv Ophthalmol. 1982;26:235–46.

    Article  CAS  PubMed  Google Scholar 

  8. Geeraets WJ, Guerry DP. Angioid streaks and sickle-cell disease. Am J Ophthalmol. 1960;49:450–70.

    Article  CAS  PubMed  Google Scholar 

  9. Hamilton AM, Pope FM, Condon PI, Slavin G, Sowter C, Ford S, et al. Angioid streaks in Jamaican patients with homozygous sickle cell disease. Br J Ophthalmol. 1981;65:341–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Nagpal KC, Asdourian G, Goldbaum M, Apple D, Goldberg MF. Angioid streaks and sickle haemoglobinopathies. Br J Ophthalmol. 1976;60:31–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Condon PI, Serjeant GR. Ocular findings of elderly cases of homozygous sickle-cell disease in Jamaica. Br J Ophthalmol. 1976;60:361–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kent D, Arya R, Aclimandos WA, Bellingham AJ, Bird AC. Screening for OPHTHALMIC manifestations of sickle cell disease in the United Kingdom. Eye. 1994;8:618–22.

    Article  PubMed  Google Scholar 

  13. Green WR, Friedman-Kien A, Banfield WG. Angioid streaks in Ehlers-Danlos syndrome. Arch Ophthalmol. 1966;76:197–204.

    Article  CAS  PubMed  Google Scholar 

  14. Perez-Roustit S, Nguyen D-T, Xerri O, Robert M-P, De Vergnes N, Mincheva Z, et al. Manifestations ophtalmologiques des syndromes d’Ehlers–Danlos: À Propos D’UNE cohorte de 21 patients. J Français d’Ophtalmol. 2019;42:722–9.

    Article  CAS  Google Scholar 

  15. Singman EL, Doyle JJ. Angioid streaks are not a common feature of Ehlers-Danlos syndrome. JAMA Ophthalmol. 2019;137:239.

    Article  PubMed  Google Scholar 

  16. Connor PJ, Juergens JL, Perry HO, Hollenhorst RW, Edwards JE. Pseudoxanthoma elasticum AND angioid streaks. Am J Med. 1961;30:537–43.

    Article  PubMed  Google Scholar 

  17. Shields JA, Federman JL, Tomer TL, Annesley WH. Angioid streaks. I. ophthalmoscopic variations and DIAGNOSTIC problems. Br J Ophthalmol. 1975;59:257–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Dabbs TR, Skjodt K. Prevalence of angioid streaks and other ocular complications of Paget’s disease of bone. Br J Ophthalmol. 1990;74:579–582.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ketner S, Moradi IE, Rosenbaum PS. Angioid streaks in association with sickle thalassemia trait. JAMA Ophthalmol. 2015;133:e141770.

    Article  PubMed  Google Scholar 

  20. Lim JI, Bressler NM, Marsh MJ, Bressler SB. Laser treatment of choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol. 1993;116:414–23.

    Article  CAS  PubMed  Google Scholar 

  21. Kumar V. Reticular pseudodrusen and thin choroid are associated with angioid streaks. Ophthalmic Surg, Lasers Imaging Retina. 2018;49:402–8.

    Article  PubMed  Google Scholar 

  22. Mansour AM, Shields JA, Annesley WH Jr, El-Baba F, Tasman W, Tomer TL. Macular degeneration in angioid streaks. Ophthalmologica. 1988;197:36–41.

    Article  CAS  PubMed  Google Scholar 

  23. Georgalas I, Papaconstantinou D, Koutsandrea C, Kalantzis G, Karagiannis D, Georgopoulos G, et al. Angioid streaks, clinical course, complications, and current therapeutic management. Ther Clin Risk Manag. 2008;81.5:81–9.

  24. Jampol LM, Acheson R, Eagle RC, Serjeant G, O’Grady R. Calcification of Bruch’s membrane in angioid streaks with homozygous sickle cell disease. Arch Ophthalmol. 1987;105:93–8.

    Article  CAS  PubMed  Google Scholar 

  25. Scholz RO. Angioid streaks. Arch Ophthalmol. 1941;26:677–695.

    Article  Google Scholar 

  26. Terry TL. Angioid streaks and osteitis deformans. Trans Am Ophthalmol Soc. 1934;32:555–573.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Gliem M, Müller PL, Birtel J, McGuinness MB, Finger RP, Herrmann P, et al. Quantitative fundus autofluorescence in pseudoxanthoma elasticum. Investig Opthalmol Vis Sci. 2017;58:6159.

    Article  CAS  Google Scholar 

  28. Gliem M, Hendig D, Finger RP, Holz FG, Charbel Issa P. Reticular pseudodrusen associated with a diseased bruch membrane in pseudoxanthoma elasticum. JAMA Ophthalmol. 2015;133:581.

    Article  PubMed  Google Scholar 

  29. Verhoeff FH. Histological findings in a case of angioid streaks. Br J Ophthalmol. 1948;32:531–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Ferris FL, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844–51.

    Article  PubMed  Google Scholar 

  31. Curcio CA, Saunders PL, Younger PW, Malek G. Peripapillary chorioretinal atrophy. Ophthalmology. 2000;107:334–43.

    Article  CAS  PubMed  Google Scholar 

  32. Tan AC, Pilgrim MG, Fearn S, Bertazzo S, Tsolaki E, Morrell AP, et al. Calcified nodules in retinal drusen are associated with disease progression in age-related macular degeneration. Sci Transl Med. 2018;10:eaat4544.

  33. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye. 1988;2:552–77.

    Article  PubMed  Google Scholar 

  34. Cesur M, Temiz F, Acıpayam C, Kılınc M, Seringec Akkececi N. Disordered bone metabolism in hereditary spherocytosis patients. Hematology. 2019;24:276–81.

    Article  CAS  PubMed  Google Scholar 

  35. McLane NJ, Grizzard WS, Kousseff BG, Hartmann RC, Sever RJ. Angioid streaks associated with hereditary spherocytosis. Am J Ophthalmol. 1984;97:444–9.

    Article  CAS  PubMed  Google Scholar 

  36. Sawada A, Oie S, Mochizuki K, Yamamoto T. Anterior ischemic optic neuropathy in patient with hereditary spherocytosis and coexisting angioid streaks. Eur J Ophthalmol. 2013;23:132–4.

    Article  Google Scholar 

  37. Felsher Z. Observations on senile elastosis. J Investig Dermatol. 1961;37:163–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

National Institutes of Health K23 Award (1K23EY025729 - 01) and University of Pennsylvania Core Grant for Vision Research (2P30EY001583). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Additional funding was provided by Research to Prevent Blindness and the Paul and Evanina Mackall Foundation. Funding from each of the above sources was received in the form of block research grants to the Scheie Eye Institute. None of the organizations had any role in the design or conduction of the study.

Author information

Authors and Affiliations

Authors

Contributions

Study idea: JN, YL. Study design: BM, BVB. Study conduction: BM, BVB. Results analysis: JN, YL BVB. Manuscript drafting: JN, YL, BVB. Critical revision of manuscript: JN, YL, BM, BVB.

Corresponding author

Correspondence to Brian L. VanderBeek.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nadelmann, J.B., Li, Y., McGeehan, B. et al. Systemic disease associations with angioid streaks in a large healthcare claims database. Eye 37, 1596–1601 (2023). https://doi.org/10.1038/s41433-022-02189-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41433-022-02189-x

This article is cited by

Search

Quick links